Minapharm Pharmaceuticals (CAI:MIPH) Gross Margin % : 38.22% (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Minapharm Pharmaceuticals's Gross Profit for the three months ended in Sep. 2024 was E£578 Mil. Minapharm Pharmaceuticals's Revenue for the three months ended in Sep. 2024 was E£1,513 Mil. Therefore, Minapharm Pharmaceuticals's Gross Margin % for the quarter that ended in Sep. 2024 was 38.22%.

The historical rank and industry rank for Minapharm Pharmaceuticals's Gross Margin % or its related term are showing as below:

CAI:MIPH' s Gross Margin % Range Over the Past 10 Years
Min: 29.51 Med: 36.75 Max: 41.33
Current: 29.51

During the past 2 years, the highest Gross Margin % of Minapharm Pharmaceuticals was 41.33%. The lowest was 29.51%. And the median was 36.75%.

CAI:MIPH's Gross Margin % is ranked worse than
80.38% of 953 companies
in the Drug Manufacturers industry
Industry Median: 47.44 vs CAI:MIPH: 29.51

Minapharm Pharmaceuticals had a gross margin of 38.22% for the quarter that ended in Sep. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Minapharm Pharmaceuticals was 0.00% per year.

Minapharm Pharmaceuticals Gross Margin % Historical Data

The historical data trend for Minapharm Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals Gross Margin % Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

Gross Margin %

41.33

32.16

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24
Gross Margin %	Get a 7-Day Free Trial			40.63	34.66	19.65	25.01	38.22

Competitive Comparison of Minapharm Pharmaceuticals's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's Gross Margin % falls into.

Save Embed

;

Save Embed

;

Minapharm Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Minapharm Pharmaceuticals's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	1251.6	/	3892.05
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(3892.05 - 2640.482)	/	3892.05
	=	32.16 %

Minapharm Pharmaceuticals's Gross Margin for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )	=	Gross Profit (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	578.2	/	1512.966
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(1512.966 - 934.719)	/	1512.966
	=	38.22 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Minapharm Pharmaceuticals (CAI:MIPH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Minapharm Pharmaceuticals had a gross margin of 38.22% for the quarter that ended in Sep. 2024 => Competition eroding margins

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Minapharm Pharmaceuticals Gross Margin % Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

https://www.minapharm.com

Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines